The steady state pharmacokinetics (PK) of atazanavir boosted with ritonavir during pregnancy and postpartum in HIV-1 infected pregnant women

Category Primary study
Registry of TrialsEU Clinical Trials Register
Year 2007
INTERVENTION: Trade Name: REYATAZ*60CPS 150MG Pharmaceutical Form: Capsule, hard Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 300‐ Trade Name: NORVIR*4FL 84CPS MOLLI 100MG Pharmaceutical Form: Capsule, soft INN or Proposed INN: Ritonavir CAS Number: 155213‐67‐5 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 100‐ CONDITION: HIV‐1 infected pregnant women PRIMARY OUTCOME: Main Objective: Primary end point(s): Secondary Objective: INCLUSION CRITERIA: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18‐64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range
Epistemonikos ID: 577fd78e13fa90eca71874745b8bed5e200aa45c
First added on: Aug 21, 2024